- Home
- » Tags
- » Epoetin theta
Top View
- (INN) for Biological and Biotechnological Substances
- Policies for Biosimilar Uptake in Europe: an Overview
- Development of Non-Overlapping Multiplex ELISA Arrays for the Quantitative Measurement of 400 Human and 200 Mouse Proteins in Parallel
- The Impact of Biosimilar Competition in Europe 2017
- Medicine Price List
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056526 A1 Dohmen Et Al
- Dorset Medicines Advisory Group Commissioning Statement on the Use of Erythropoiesis-Stimulating Agents (Epoetin and Darbopo
- Erythropoiesis-Stimulating Agents
- Epoetin Alfa for the Treatment of Myelodysplastic Syndrome-Related
- Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: a Randomised Controlled Trial
- ROXADUSTAT) FIBROGEN* Phase II Studies Completed (ND CKD, HD, PD) Phase III Studies Ongoing (ND CKD, HD, PD)
- Biosimilar Labelling Workshop
- Minutes of the CHMP Meeting 17-20 May 2021
- Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity Without Compromising Cisplatin Anticancer Properties
- The Impact of Biosimilar Competition in Europe Contents
- Erythropoiesis-Stimulating Agents – Oxford Clinical Policy
- Eporatio, INN-Epoetin Theta
- WHO EML 2016-2017 - Erythropoietin-Stimulating Agents December 2016
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Past, Present and Future of Erythropoietin Use in Anemia in Older Adults
- December 20, 2013 Division of Dockets Management Food And
- Universidade De Lisboa Faculdade De Farmácia
- List Item Minutes of the CHMP Meeting 17-20 July 2017
- THE IMPACT of BIOSIMILAR COMPETITION in EUROPE October 2019
- Rhepo for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits
- (PDF) Download
- Experience with Epoetin Theta in the Management of Chemotherapy Induced Anemia in Spain: a Post-Authorization Cohort Study © Permanyer Publications 2014
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Epoetin Alfa, Beta, Theta and Zeta; And, Darbepoetin Alfa) for Treating Cancer- Treatment Induced Anaemia (Including Review of TA142
- Epoetin Theta
- PHARMACOECONOMIC ANALYSIS of EPORATIO for TREATMENT of ANEMIA in CANCER PATIENTS Kulikov A.Yu.1, Ugrekhelidze D.T.1, Snegovoy A.V.2
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- CHMP Agenda of the 19-22 July 2021 Meeting
- United States Patent (10 ) Patent No.: US 10,632,134 B2 Thatte Et Al